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We have shown that both xenografts and allografts of rat skin can be acutely and 
severely damaged by antisera  specifically reactive with  graft  antigens,  and  that  in 
appropriate circumstances the phenomenon can be elicited routinely (1, 2). A matter 
of paramount importance among the variables that influence the occurrence of this 
form of immunologically mediated tissue damage is the interval of time between the 
placement of the grafts and the administration of antiserum  (3).  Contrary to widely 
held  views on the special  vulnerability of grafts  that  are healing into place,  it  has 
been found that antiserum injected at the time of grafting or within 5-6 d thereafter 
has little  detectable influence on the course or time of survival of the transplanted 
skin.  This period of insusceptibility  is rapidly succeeded by a  state of sensitivity to 
humoral  antibody that,  in  immunosuppressed  hosts,  reaches a  peak of intensity at 
about  14-16 d after grafting and persists at decreasing levels  for an additional 3 wk. 
Grafts that survive beyond that period of time regain their resistance to antiserum, 
and this state is maintained for the duration of survival of the grafts. 
We have analyzed these changes in the responses of xenografts of skin to antisera, 
and we have found that the initial state of insensitivity differs substantively from that 
observed in long-standing grafts. We describe here the results of our studies on freshly 
placed grafts, and in a succeeding paper (4) we report on the mechanisms involved in 
the acquired resistance of grafts that have survived for relatively long periods of time. 
Materials and Methods 
Animals.  B6AF1  and CAFa mice were purchased from The Jackson Laboratory, Bar Harbor, 
Maine.  Lewis (LE) and (Le ×  BN)F1 hybrid rats  (LBN) were obtained from Microbiological 
Associates, Walkersville,  Md.  CD  rats  were  purchased  from  the  Charles  River  Breeding 
Laboratories,  Wilmington,  Mass. 
Antisera.  Rabbit anti-mouse  thymocyte serum (RAMTS) 1 was prepared as described (5) or 
was obtained from Microbiological Associates. 13 pools of antisera  were used, the least potent 
of which extended  the mean survival  time of rat skin grafts to 32.5 :t:  ! 1 d.  Rabbit anti-rat 
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1 Abbreviations used in this paper: MARS, mouse anti-rat serum; RAMTS, rabbit anti-mouse thymocyte 
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serum  (RARS) was prepared by injecting mixtures of rat thymus and lymph node cells into 
rabbits according to the schedule used  for preparing RAMTS.  Portions of this serum were 
absorbed with mouse cells to remove cross-reacting antibodies. Mouse anti-rat serum (MARS) 
was prepared in B6AF1 and CAFI mice by injecting them at weekly intervals with  107-108 rat 
lymphoid cells per mouse. Mice were bled each week and a single large pool of antiserum was 
made. In some cases the rat cells were emulsified with Freund's complete adjuvant and injected 
intraperitoneally at weekly intervals until ascites developed. The ascites fluid was collected, 
pooled, and used in some experiments in place of MARS. There were no detectable differences 
in the biological activities of the serum and ascites fluid, and for convenience both are referred 
to as MARS. 
Skin Grafts.  Ear skin was grafted as described previously (5). Individual grafts measured 15-- 
20 mm along the longest diameter and 14-15 mm along the shortest diameter. Grafts that were 
to be retransplanted to new recipients were excised from their primary hosts together with a 
cuff of surrounding host skin. Subcutaneous tissue was removed from the undersurface of the 
graft  by carefully scraping with  a  No.  10  surgical blade. As the secondary recipients were 
syngeneic to the primary ones, it was unnecessary to remove the cuff of primary host tissue 
before regrafting. All grafts were anchored to their beds at several points through the use of 
collodion flexible (Merck Chemical Division, Merck and Co., Rahway, N. J.). This procedure 
was especially helpful when two grafts were placed simultaneously on the same recipient. 
In those special cases in which dressings were not applied to the grafts, the skin was held in 
place by interrupted sutures of 6-0 silk thread. To prevent damage to these grafts, the toenails 
of the recipients were clipped. 
Experimental System.  Mice were thymectomized 2-3 wk before receiving rat skin grafts, and 
they were injected intraperitoneally with 0.25 ml of RAMTS 2 d before grafting, on the day of 
grafting, and  on  the  2nd  and  4th  d  after  placement  of the  grafts.  At  various  times  after 
transplantation they were injected with MARS and the effects of these injections on the grafts 
were studied. 
Immunofluorescent Studies.  Grafts were excised from their hosts and cryostat sections of them 
were prepared for studies with  fluorescent antisera as described previously (6).  Fluorescein- 
conjugated antibodies reactive with rabbit IgG, mouse IgG, mouse C3, chicken IgG, or mouse 
serum albumin were obtained from N. L. Cappel Laboratories (Cochranville, Pa.).  In some 
experiments, the hosts had been injected with anti-graft serum before removal of the grafts, 
and  in these cases sections of tissue were stained directly with fluoresceinated anti-immuno- 
globulin (Ig) or anti-C3 reagents. In other cases, sections of frozen skin were treated in vitro 
with MARS or rat anti-mouse serum and then with fluoresceinated anti-Ig serum of appropriate 
specificity. 
Results 
Sensitivity  of  Skin  Grafts  to  MARS  Administered  at  Various  Intervals  after 
Transplantation.  Table  I  contains  a  summary  of the  results  of a  large  number  of 
experiments in which MARS was administered on the day of transplantation or at a 
single  interval  thereafter.  As we  have  reported  previously  (2,  3),  the  effects  of the 
antiserum  depend  largely on  the  time  at  which  it  is  given  relative  to  the  time  of 
grafting. MARS given to 114 graft recipients during the first 6 d  after transplantation 
had no evident effect on the healing processes or on the time of survival of the grafts. 
However, the sensitivity of the grafts increased sharply over the next week, reaching 
a  peak at  14-16 d, and then declined steadily over the next 3 wk. During the period 
of peak sensitivity, intense inflammatory responses characterized by edema, erythema, 
and local hemorrhage were induced in  181  of 194 grafts that were tested, and  171  of 
these grafts were destroyed as an  immediate consequence  of the antibody-mediated 
inflammation. The small number of grafts (13 of 194 tested) that were unaffected by 
antiserum administered at  14-16 d  after grafting were retested 2-3 d  later and all but 
2  were  susceptible to  the  second  injection  of MARS.  There  are  thus  striking and JOOSTE ET AL. 
TABLE I 
Response of Rat Skin Grafts to MARS Administered at Various Intervals 
after Transplantation 
Graft destruc-  Day of injection*  Number of mice  Inflammation:~  tion§ 
%  % 
0-6  114  --[[  0 
8  I0  --  30 
9-12  29  90  72 
13-16  194  93  88 
17-25  46  89  67 
26-36  40  58  10 
38-66  47  0  0 
* Each mouse received 0.5 ml of MARS intraperitoneally. 
Erythema, edema, and local hemorrhage. 
§ These figures indicate the percentage of cases in which graft destruction was 
an immediate consequence of the inflammation induced by antiserum. 
II These grafts were covered by dressings at the time of testing and were not 
observed for changes during the period immediately after the administration 
of antiserum. 
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unexpected differences between the reactions of freshly placed and established  xeno- 
grafts  of skin  to  the  injection  of anti-graft  sera.  These  differences  were  observed 
consistently  when  a  wide  variety  of pure  strain  and  Fa  hybrid  mice  were  used  as 
recipients  of rat  skin  grafts, and  also when  allografts of rat  skin  were used  (2).  The 
insensitivity of freshly grafted skin to antiserum seems, therefore, to be of widespread 
occurrence and the basis of such insensitivity, which is of potential interest  from both 
practical and conceptual points of view, is analyzed in the following experiments. 
Influence  of Surgical  Dressings  and the Regimen  of lmmunosuppression  on  the Responses  of 
Freshly Placed Rat Skin Grafts to MARS.  We were initially concerned that the resistance 
of freshly placed grafts might turn on the unusual circumstances in which they were 
tested.  At the  time of challenge,  these grafts were covered with  protective dressings 
that were kept in place until the 8th d  after grafting. It seemed possible that MARS 
did in fact cause inflammation  in the graft beds but that the dressings protected  the 
grafts from extensive damage and enabled  them to heal, or in some cases to re-heal, 
into their beds. However, when grafts were sewn into place on the recipients, and the 
dressings were omitted,  the period of early resistance  was still  observed.  None of 52 
such  grafts  that  were  challenged  on  days  0-8  after  grafting  were  visibly  affected, 
whereas  all  of 9  grafts  challenged  on  day  14  with  MARS  were  acutely  destroyed. 
Furthermore,  12  grafts  that  had  been  in  place  for  14  d  were  rebandaged  before 
challenge with MARS and all of them were fully susceptible to that agent. 
The circumstances in which early grafts were challenged with MARS were unusual 
insofar as their  responses  may have been  modified  by the concurrent  or proximate 
administration  of the  RAMTS  used  as a  suppressive  agent.  However,  that  was not 
the case, as shown by the results of experiments  in which RAMTS  was given well in 
advance of grafting (12,  10, 8, and 6 d  before transplantation).  Grafts were placed on 
33 mice, small  groups of which were injected with MARS at 0, 3, 4, 6,  10,  14, or  16 
d later. The development of sensitivity to antiserum in these grafts paralleled precisely 
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to our regularly used schedule.  None of 21  grafts tested through day 6 was sensitive; 
one of 4  tested on day  10,  and all of 6  tested on days  14 or  16 were destroyed as a 
result of the administration of antiserum.  Moreover, the same pattern of acquisition 
of sensitivity to MARS was observed for grafts placed on 20 BALB/c nu/nu mice that 
received no RAMTS. 
Detection of Ig and C3 on the  Vessels of New Grafts after the Injection of Their Hosts with 
Anti-Graft Sera.  Our earlier studies had indicated  that antiserum-mediated destruc- 
tion of skin grafts is a consequence of an acute and intense vasculitis initiated by the 
reaction of antibodies with antigens on endothelial cells of the grafts. This view was 
strongly supported by the results of studies showing, through the use of immunofluo- 
rescent  reagents,  the  presence of Ig and  C3  on  the  luminal  surface of graft  vessels 
within  minutes of the injection  of MARS or RARS  (7).  We have looked, therefore, 
for the deposition of Ig and C3 in vessels, or other parts of freshly grafted skin, during 
the period when it is insensitive to MARS. Anti-graft serum, either MARS or RARS 
that had been absorbed with mouse tissues, was injected intraperitoneally at a dose of 
0.5  ml, and the grafts were removed 2-4 h  later and prepared for examination with 
fluoresceinated  antisera  as  described  elsewhere  (6).  Rabbit  antiserum  was  used  in 
some experiments because it was thought to facilitate the distinction between endog- 
enous and injected immunoglobulins in this experimental system. 
In practice there was little difference in  the observations made with  RARS  and 
MARS,  but  it is clearer in the case of RARS  that  the Ig on the vessel walls comes 
from the injected material. In Table II, we present results of a study in which RARS 
was injected into mice bearing rat skin grafts that had been in place for 2-7 d. 
None of five grafts that had been in place for 2 d  at the time of administration of 
RARS contained vessels that were stained with fluoresceinated antisera, and in only 
one of three  grafts that  were removed on  day 3  after grafting were stained  vessels 
found. In that graft, only a small number of vessels were stained with anti-Ig (< 10%) 
or anti-C3  (<20%).  When  RARS was injected on day 4,  there was widespread and 
readily detectable staining of the luminal surface of vessels by both anti-Ig and anti- 
C3 in five of eight grafts tested.  Beginning on day 5, all grafts tested had numerous 
TABLE  II 
Detection of Injected Ig and Endogenous C3 in the Vessels of Rat Skin Grafts during the 1st 
wk after Transplantation* 
Day of injection  Number of mice 
Number grafts with vessels stained by 
Anti-mouse  Anti-mouse 
Anti-rabbit Ig  C3  Ig 
2  5  0  0  0 
3  3  1,  1,  o 
4  8  5  5  0 
5  3  3  3  0 
6  3  3  3  0 
7  3  3  3  0 
* Recipients were injected intraperitoneally on the days indicated with 0.5 ml of RARS that 
had  been  absorbed with  mouse tissues.  4  h  later,  the  grafts were  removed  and  frozen 
sections of them were stained with fluoresceinated antibodies of the specificities  indicated. 
Mouse skin from these animals were unstained by all  of the reagents used. 
:~ Staining of < 10% of vessels with anti-Ig and <20% with anti-C3. JOOSTE ET AL.  1323 
vessels that stained  with both anti-rabbit  Ig and anti-mouse C3, as shown in Fig.  1. 
In none of the cases in this entire series of experiments was there notable staining of 
vessels or other graft elements with anti-mouse Ig or anti-mouse albumin, although a 
diffuse blush in the edematous connective tissue was seen. Deposition of Ig and C3 on 
the  luminal  surfaces  of graft  vessels was again  readily  detected  through  the  use  of 
fluoresceinated antisera after injecting the graft bearers with MARS  (Fig. 2). 
The patterns  of staining described  here are fully consistent  with  numerous obser- 
vations on the time of vascularization of free grafts of skin, viz., that circulation is first 
detected  on day 3-4 after  grafting and  is  abundant  thereafter.  More  important  for 
the present study, these data show conclusively that Ig and complement components 
reach  and  react  with  endothelial  cells  of the  grafts  at  a  time  when  they  are  still 
completely resistant  to anti-graft  serum.  Thus the resistance of the grafts appears  to 
be  related  either  to  their  transient  insensitivity  to  the  mediators  developed  by  the 
immune reactions  taking place within  the graft  vessels or to local depletion  of such 
mediators. 
Development  of Sensitivity  to Antiserum  in  Grafts Placed Simultaneously  on  the Same Recipi- 
ent.  Primarily  vaseularized  grafts of rat  hearts  and  rat  kidneys placed  in  mice are 
sensitive to antisera  immediately after transplantation  (8)  and remain so for at  least 
8 wk thereafter,  which suggests that the resistance of freshly placed grafts of skin can 
Fro.  1.  lmmunofluorescence photomicrographs of a rat skin xenograft 14 d after grafting onto an 
immunosuppressed mouse and 4 h after RARS was given intraperitoneally. The cryostat section, 
stained with fluorescein-conjugated anti-rabbit  lgG, shows bright fluorescence  along the endothe- 
lium of the microvasculature of the graft (A) but not in the connective tissue or epidermis (e). The 
vessels in the graft (g) but not in graft bed (gb) show bright staining (B). 1324  RESISTANCE  OF  XENOGRAFTS  OF  SKIN TO ANTISERUM 
Flo. 2.  14-d  rat Skin xenograft from a B10.D2 old (C5 deficient) mouse given MARS intraperito- 
neally 3 h earlier and stained in vitro with fluorescein-conjugated  anti-mouse C3. The endothelium 
of the graft vessels stains brightly. The epidermis (e) and connective tissue are negative. 
be traced to factors acting locally within  the grafts. This point was examined  in the 
present  study by placing  two skin  grafts simultaneously  on  the same  recipient  and 
testing their responses to antiserum at various intervals after grafting. A predominant 
systemic influence would be indicated if grafts on the same animal invariably acquired 
sensitivity to antiserum  at the same time, whereas the importance of local conditions 
would be indicated if in some animals one graft developed sensitivity, while the other 
remained  resistant  to antiserum.  The distinction  may, of course, be blurred  to some 
extent  by the influence  of the general  physiological state  of the  recipient  on locally 
acting factors. 
Immunosuppressed  B6AF1  mice  received  two  rat  skin  grafts  placed  on  opposite 
flanks.  6-15  d  later,  these  recipients  received  a  single  injection  of MARS,  and  the 
grafts were examined periodically for signs of inflammation  and tissue damage. The 
results  of this  experiment  are  summarized  in  Table  III. Various  degrees  of inflam- 
mation  were  detected  in  all  but  one  graft,  but  in  many  cases  there  were  striking 
differences in the intensity of responses of grafts on the same mouse. These differences 
were observed  in  mice of all  groups but  they were more common among mice that 
received  MARS on days 6, 7, or 8  after grafting. The differences  are best  illustrated 
by  considering  the  incidences  of graft  destruction  that  occurred  as  an  immediate 
consequence of the administration  of antiserum.  When recipients were injected with 
MARS on days 6-8,  7 of 25 mice that were tested had one graft that was destroyed, JOOSTE ET AL. 
TABLE III 
Development of Sensitivity of MARS in Skin Grafts Placed Simultaneously on 
the Same Recipients* 
Day of injec-  Number of  Both grafts  Neither  One graft 
tion of MARS:I:  mice  destroyed  destroyed  destroyed 
6  8  0  5  3 
7  11  4  4  3 
8  6  5  0  1 
9-15  14  13  0  1 
* Each mouse received two grafts placed simultaneously on the left and right 
flanks. 
:~ MARS was injected intraperitoneally at doses ranging from 0.1  to 1.0 ml 
within each group. Inflammation occurred in all but one graft. 
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whereas the other survived (Table III). In mice tested on days 9-15, all but one graft 
was destroyed;  in one mouse injected on day  14,  both grafts showed intense  inflam- 
mation, but one recovered completely. 
These  results  show that  the  development  of sensitivity  to antiserum  can  proceed 
independently  in  each  of two  grafts  placed  simultaneously  on  one  recipient;  and, 
accordingly, they provide evidence for the influence of local factors on this process. 
Reversibility  of the  Acquired  Sensitivity  of Grafts  to  Antisera  after  Their  Transfer  to  New 
Hosts.  It is clear from the experiments described above that freshly placed skin grafts 
may remain resistant  to antisera even after they have become vascularized, and even 
though their vessel walls bind immunoglobulins and C3. Furthermore,  it is clear that 
the transition from resistance to susceptibility to antisera involves local changes in the 
grafts. Are these changes related  to the processes by which the grafts heal into place 
or are  they in some way induced by the  new hosts?  In our attempts  to resolve this 
issue, we have determined the extent to which a  state of recently acquired sensitivity 
can  be  reversed  by retransplanting  skin  to  new  immunosuppressed  recipients.  Rat 
skin was transplanted  to immunosuppressed  mice and allowed to remain in place for 
either  5  or  13  d.  The  grafts  were  then  removed  and  transplanted  to  secondary 
immunosuppressed hosts of the same genotype as the initial recipients. These second- 
ary recipients  received a  single  injection of 0.5 ml of MARS on day  1, 6,  14, or  15. 
The  results  of this  experiment  are  presented  in  Table  IV.  Grafts  that  had  been  in 
place on primary recipients  for  13 d, and could therefore be confidently assumed to 
have developed a  state of intense sensitivity  to MARS, became completely resistant 
to this agent when  grafted to new recipients;  this state of resistance was maintained 
for at least 6 d. However, when retransplanted  skin was tested at  14 d  after grafting, 
it  was  completely  susceptible  to  MARS,  as  were  control  grafts  that  had  been  in 
residence on a single host for 14 d. The development of susceptibility to MARS seems 
not to involve permanent loss or gain of any substance in the graft. Rather, the short- 
lived  insensitivity  of  freshly  placed  grafts  seems  to  be  associated  with  processes 
involved in the healing of free grafts. 
Effect of MARS Injected Intracutaneously  into Rats.  Further evidence that the resistance 
of freshly grafted skin to antisera is related to the healing process rather than to host- 
induced  alterations  comes from experiments  in which  MARS was  injected  intracu- 
taneously into rats.  Individual  rats  received  injections of 0.05  ml of various concen- 
trations of antiserum  at several sites along the dorsal surface of the trunk, and these 1326  RESISTANCE OF XENOGRAFTS OF SKIN TO  ANTISERUM 
TABLE  IV 
Effect of MARS on Rat Skin That Had Been Transplanted to Secondary 
Recipients* 
Skin regrafted at  Skin regrafted 
13d  at5d  Day of injection:~  Fresh grafts§  (number  (number tested) 
destroyed) 
1  0/4  0/8  0/4 
6  0/2  0/6  0/4 
14, 15  5/5  10/10  5/5 
* Rat skin was transplanted to immunosuppressed B6AFI mice and at 5 or 13 
d after grafting the skin was removed and placed on new immunosuppressed 
B6AF1 mice. 
:~ Day 0 is taken as time of secondary grafting. Each mouse received 0.5 ml of 
MARS intraperitoneally. 
§ Control mice received fresh grafts only on day 0. 
350 -  #~t/t) 
" 300- 
_~  250- 
~200- 
i  150- 
,oo t/'  <,,.,,  \l 
5o 
2  6)  2  24 
TIME AFTER MARS (HRS) 
_(1/I) 
0/2) 
/?......:."' 
UIf  ,~  -c,/,61 
2  6~  24 
TIME AFTER MARS (HRS) 
Fro.  3.  The effect of MARS administered intracutaneously to rats.  Multiple sites were injected 
with  0.05  ml  of undiluted  serum  or  a  dilution  thereof,  up  to  1:16. Normal  serum  (NS)  was 
administered as a control.  Data are presented for 2 of 10 rats that were treated. 
sites  were  monitored  for signs  of inflammation  and  tissue  damage.  In  all  of  10  rats 
that were so treated, MARS  caused intense inflammatory  responses that proceeded to 
necrosis at the higher concentrations  of serum.  The courses of the reactions in typical 
recipient rats are presented  in Fig.  3. The data shown  in the figure were obtained  by 
measuring two diameters of the lesions, which were circular, and using the average of 
these measurements  to calculate the areas of erythema  and  induration. 
Normal  serum caused small amounts  of edema  that  were measurable  at  1-2 h  but 
were  almost  completely  resolved  6.5  h  after  injection.  Sites  of injection  of MARS 
developed  edema  and  erythema  by  1-2  h  and  at  6.5  h  there  was  necrosis  that 
measured  up  to 0.5  ×  0.5  cm. The  lesions reached  a  peak of intensity  at  4-8 h,  and JOOSTE  ET  AL.  1327 
resolved gradually over a  period of 3-5 d. The evolution of these lesions followed a 
course very similar to that seen in skin grafts after treatment of their hosts with anti- 
graft serum. They were not typical Arthus reactions, however, as indicated by the fact 
that we were unable to detect in MARS any precipitating antibodies for rat serum or 
tissue extracts. Thus, skin is fully sensitive to antiserum when it is removed from the 
donor rats and on being transplanted it enters a state of resistance that persists for 5 
or 6  d.  This  observation  clearly supports  the  notion  that  the  period  of resistance 
occurring immediately after grafting is related to the processes by which  free grafts 
heal into place and become vascularized. 
Rechallenge  on Day 14 of Skin Grafts  That Had Been Found Resistant to MARS Immediately 
after Grafting.  We have shown conclusively that anti-graft serum administered during 
the first 5-7 d after grafting has no detectable effect on the survival of grafts, although 
it had in many instances led to the deposition of Ig and C3 on the luminal surfaces of 
graft vessels. Moreover, these grafts remained intact even after they had reached an 
age at which  they should have developed susceptibility.  It was therefore of interest, 
especially in view of our observations on the replacement of donor endothelium  by 
host cells in long-term skin grafts (8), to determine the susceptibility at  14 d  of those 
grafts that  had previously displayed resistance to MARS.  We wanted  to determine 
whether  the  early  administration  of antiserum  had  in  any  way  damaged  donor 
endothelium, leading to its replacement by host cells and accompanying resistance to 
antiserum. 
As indicated in Table V, 22 mice whose grafts had been resistant to MARS injected 
on day 1, 4, 6, or 8 after transplantation were again injected with antiserum when the 
grafts were  14 d  old. Intense inflammatory responses developed in all of these grafts 
within  1 or 2 h  after administration of serum, and 21 of the 22 grafts were destroyed 
as a  result of the inflammation. Thus, there is no indication  that  the interaction of 
antibody and complement with endothelial cell surfaces in freshly placed grafts causes 
irreparable damage to such cells. 
Discussion 
The  resistance  of freshly  placed  grafts  of skin  to  antisera  has  in  a  sense  been 
established for many years, for there are numerous reports that record the failure of 
antisera, administered at the time of transplantation,  to influence the fate of grafted 
TABLE  V 
Effect of the Administration of MARS during the 1st wk after Grafting on the 
Later Sensitivity of the Grafts to Antiserum Given at 14 d after Grafting* 
Graft destruction:[:  Inflammation:[: (2rid 
Day of 1st MARS 
1st MARS  2nd MARS  MARS)§ 
1-4  0/18  17/18  18/18 
6-7  0/5  5/5  5/5 
--  --  8/l 1  10/11 
* B6AFI mice bearing Le skin grafts received 0.5 ml of MARS during the 1st 
wk after grafting and again at day 14. 
:~ Number positive/number injected. 
§ Grafts were covered by dressings at the time of the first injection of MARS. 
Accordingly, occurrence of inflammation could not be determined. 1328  RESISTANCE OF XENOGRAFTS OF SKIN TO ANTISERUM 
skin (9). Until recently, however, it was not appreciated that this state of resistance is 
transient,  and  that  grafts that  survive for sufficiently long periods of time become 
highly susceptible to antiserum. This gradual development of sensitivity of skin grafts 
to humoral antibody has been observed by us in large numbers of rats and mice of 
diverse genotypes and its occurrence has been confirmed by Gerlag et al. (10) in their 
studies with mice. It is a phenomenon that is surprising in part because of intuitive 
feelings that  grafts that are healing into place should be more vulnerable to immu- 
nologic assault than are established grafts; and in part because other types of grafts, 
e.g., primarily vascularized grafts of hearts and kidneys, are fully sensitive to antisera 
from the moment that transplantation is technically completed. Grafts of tumor cells 
are also sensitive to antiserum  immediately after they are placed in new hosts and 
indeed their sensitivity, which is at a peak at this point, is rapidly lost thereafter. Why 
then should grafts of skin be completely insensitive to humoral antibodies in experi- 
mental circumstances in which grafts of other kinds are so susceptible to these agents? 
The data that we present here show conclusively that the resistance of freshly grafted 
skin does not turn on the protective effects of the dressings that have been used, nor 
can it be attributed to the regimen of immunosuppression that was used in many of 
the experiments. Furthermore, a delay in the development of sensitivity occurs in the 
case of skin grafts, but not in the case of grafts of other kinds that are transplanted in 
similar  circumstances, which  points  to  the  importance of factors operating  locally 
rather than systemically. This conclusion is supported by the observation that when 
mice receive two skin  grafts simultaneously,  the  grafts often develop sensitivity at 
different rates, and, as shown here, one graft may be severely damaged by antiserum, 
whereas a contralaterally placed graft is not noticeably affected. An explanation for 
the exceptional behavior of skin grafts must then be sought in local conditions that 
are peculiar to such grafts. 
Free  grafts  of skin,  unlike  primarily  vascularized  grafts,  do not  have  vascular 
connections with their hosts until about the 4th d after transplantation, a point that 
is affirmed by our studies with fluorescein-labeled antibodies. It would not be possible, 
therefore, to  induce  immediate  vascular  injury in  recently placed  grafts,  and  the 
induction  of  vascular  injury  seems  to  be  a  sine  qua  non  of  antiserum-mediated 
destruction of organized tissue grafts (4). This explains the resistance of grafts for the 
1st  4  d  after  transplantation,  but  even  after  grafts  are  vascularized  they  remain 
resistant to antiserum for an additional 2 or 3 d  and peak sensitivity is not acquired 
until about the 12th or 14th d after grafting. This is surprising in view of the fact that 
it can be shown that  the luminal surfaces of the vessels  of these grafts bind readily 
detectable  amounts  of injected  antibody,  which  in  turn  bind  detectable  levels of 
endogenous C3. The resistance of grafts in these circumstances is clearly not attrib- 
utable to the failure of primary effector substances to reach their targets. It is more 
likely that the target tissue fails to respond to the effector substances. 
This state of indifference or nonresponsiveness to phlogistic substances is associated 
with the technical procedure of grafting, a conclusion based largely on two observa- 
tions reported here. First, skin is sensitive to antiserum just before it is removed from 
the donor rats and again at about  7 or 8 d  after transplantation.  It is resistant only 
during  the  period  immediately  following  grafting.  Second,  grafted  skin  that  has 
developed  a  high  degree  of sensitivity  to  antiserum  loses  that  sensitivity  if it  is 
regrafted, and then subsequently regains it. Evidently, the resistance of freshly grafted JOOSTE ET AL.  1329 
skin to antiserum derives from the early effects of transplantation on vessels  within 
the graft and the graft bed. These vessels  are subjected to mechanical  trauma and 
anoxia during the transplantation  procedure and their recovery from such damage 
entails vascular regeneration as well as the formation of new vessels.  It is known that 
newly  formed  and  regenerating  vessels  of  the  microvasculature  are  structurally 
immature,  and  Hurley (11)  has  reported that  the vessels  in  granulation  tissue  are 
unresponsive to vasoactive substances for several days or weeks after they are formed. 
He  has  suggested that  this  lack  of responsiveness  may be  essential  to  the  proper 
development of vessels,  especially those that  are  forming in  areas  of inflammation 
that abound in vasoactive materials. In any event, it supplies an adequate explanation 
for the resistance of freshly placed grafts to antiserum. The young vessels in the graft 
and  adjacent  bed  are  unable  to  respond  to  the  vasoactive  materials  released  or 
activated by the reaction of antibodies with graft antigens, and because tissue damage 
occurs secondarily to vascular injury the graft is spared. This explanation is entirely 
consistent  with  the  observation  that  primarily  vascularized  grafts  of hearts  and 
kidneys are sensitive to antisera immediately after transplantation, for in these grafts 
there is no need for regeneration of the microvasculature and  hence no reason for 
transient resistance to vasoactive substances. It is also consistent with our observations 
that long-term skin grafts, in which graft endothelium has been replaced by host cells, 
become resistant to antisera, for in this circumstance antibodies specifically reactive 
with graft antigens can no longer combine with endothelial cells to trigger the vascular 
injury that underlies graft destruction. Hence, the oft-reported resistance of skin grafts 
to humoral antibodies is not, as previously thought, due to peculiar properties of skin 
per se, but to peculiar properties of newly formed and regenerating blood vessels  that 
are essential to the healing process. 
Endothelial cells are not the only ceils that are subjected to anoxia and trauma in 
the grafting procedure, and it is possible that damage to other elements of skin grafts 
contributes to their transient  resistance to  antiserum.  Disruption  of mast  cells,  for 
example, may lead to temporary loss  of sources of vasoactive materials that  play a 
role in antibody-mediated damage to tissues. Such a  process would act in a  manner 
complementary to the postulated low state of responsiveness of regenerating vessels to 
inflammatory stimuli. 
The sensitivity of freshly grafted tumor cells to humoral antibody is not inconsistent 
with these views on the resistance of skin grafts.  As we have pointed out elsewhere 
(12), the mechanisms involved in the destruction of tumors by antiserum are highly 
effective against  small  numbers of targets,  but  their effectiveness is very noticeably 
diminished as the size of the tumor graft is increased. These mechanisms can scarcely 
be expected to influence the course of free grafts of skin or primarily vascularized 
grafts  of hearts  or  kidneys.  The  vulnerability  of tumors  to  antiserum  decreases 
progressively after grafting, which may be due to the corresponding increase in the 
size of the tumor or to the isolation of the tumor by the vasculature supplied by the 
host.  This and  other aspects of the  role of the  vascular bed  in  antibody-mediated 
damage to tissues is considered in more detail in the following report (4). 
Summary 
Rat skin grafted onto immunosuppressed mice is resistant to mouse anti-rat serum 
during  the  first  7-10  d  after  transplantation.  It  gradually  acquires  susceptibility, 1330  RESISTANCE OF  XENOGRAFTS  OF  SKIN TO ANTISERUM 
reaching a  peak of sensitivity at  14-16 d  after grafting. The grafts remain sensitive to 
antiserum,  though  at decreasing levels for an additional  3 wk, and grafts that persist 
beyond  that  time are resistant  to antiserum  for as long as they survive.  In the study 
reported  here,  it  is shown  that  the initial  period  of resistance  to antiserum  is due  to 
factors acting locally within  the graft and  is entirely uninfluenced  by the regimen of 
immunosuppression  or the protective dressings that are used. After administration  of 
antiserum,  deposits of the injected  immunoglobulin  and of endogenous C3 are found 
on  the  luminal  surfaces  of graft  vessels,  although  no  significant  tissue  damage  is 
observed. 
Rat skin that has become highly sensitive to antiserum  14-16 d after transplantation 
loses that  sensitivity  if it  is regrafted  to a  new  recipient,  and  then  regains  it  8-10  d 
later.  Thus,  the  resistance  of freshly  grafted  skin  to  antisera  is  associated  with  the 
process of healing  into place,  a  conclusion  that  is supported  by the observation  that 
the intracutaneous  administration  of antisera to rats causes intense local inflammation 
and necrosis.  The skin  is therefore sensitive just  before it is removed for grafting,  but 
temporarily  loses sensitivity  thereafter.  Resistance  to antiserum  during  the  first  3 or 
4  d  after transplantation  is probably attributable  to the fact that  at that  time grafts 
are vascularized  poorly if at all. The state of resistance extends  for several days after 
vascularization of the graft takes place and is then only gradually lost, a  phenomenon 
that  seems  to  be  associated  with  the  resistance  of newly  formed  and  regenerating 
blood  vessels  to  vasoactive  substances.  This  view  is  in  accord  with  and,  indeed, 
supports the idea that the induction  of vascular injury is an essential step in antisera- 
mediated damage to tissue grafts. 
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